Cramb G, Griffiths N M, Aiton J F, Simmons N L
Biochem Pharmacol. 1984 Jun 15;33(12):1969-76. doi: 10.1016/0006-2952(84)90557-4.
The biochemical and physiological aspects of isoprenaline sensitivity in normotensive rats were examined during and after abrupt withdrawal of chronic propranolol treatment. Serum propranolol concentrations in rats chronically treated for one month (0.125% propranolol in drinking water: 75-100 mg/kg/day) ranged from 7 to 23 ng/ml. At the height of the blockade, rats showed a decreased responsiveness in vivo to isoprenaline-induced increase in heart rate and fall in blood pressure; the ED50 values for isoprenaline being increased some 20- and 4-fold respectively. There was a 180% increase in beta-receptor number in sarcolemmal membranes isolated from ventricular muscle of these animals, together with increased basal (290%), fluoride- (100%), forskolin- (80%) and isoprenaline-stimulated (125%) adenylate cyclase activity. Twenty-four hours after propranolol withdrawal, serum propranolol concentrations were reduced by over 95%. At this time rats exhibited increased chronotropic and blood pressure responses to i.v. isoprenaline, indicated by the reduced ED50 values (2-fold and 12-fold respectively compared to controls). In addition, cardiac sarcolemmal beta-receptor number and adenylate cyclase activities were still significantly elevated above those of controls; 35% increase in beta-receptor number and increases of 96, 26, 13 and 37% in basal, fluoride-, forskolin- and isoprenaline-stimulated adenylate cyclase activities respectively. Forty-eight hours after drug withdrawal serum propranolol concentrations were only just detectable at 0.5 +/- 0.1 ng/ml. Although sarcolemmal beta-receptor numbers were still elevated (23%) isoprenaline-stimulated adenylate cyclase activity had returned to control values. However, both the fluoride- and forskolin-stimulated enzyme activities were decreased below control values by 12 and 23% respectively, suggestive of a reduction in the catalytic capacity of the adenylate cyclase complex. In parallel with the reduction in beta-receptor number and adenylate cyclase activity, the chronotropic response to i.v. isoprenaline had also returned to control values. In contrast, the blood pressure response to i.v. isoprenaline was still elevated in these animals indicated by the 5-fold reduction in the ED50 value compared with control animals.
在长期普萘洛尔治疗突然停药期间及之后,研究了正常血压大鼠对异丙肾上腺素敏感性的生化和生理方面。长期接受一个月治疗(饮用水中含0.125%普萘洛尔:75 - 100毫克/千克/天)的大鼠血清普萘洛尔浓度范围为7至23纳克/毫升。在阻断作用达到高峰时,大鼠体内对异丙肾上腺素诱导的心率增加和血压下降的反应性降低;异丙肾上腺素的半数有效剂量(ED50)值分别增加了约20倍和4倍。从这些动物心室肌分离的肌膜中β受体数量增加了180%,同时基础腺苷酸环化酶活性(增加290%)、氟化物刺激的活性(增加100%)、福斯高林刺激的活性(增加80%)和异丙肾上腺素刺激的活性(增加125%)也有所增加。普萘洛尔停药24小时后,血清普萘洛尔浓度降低了95%以上。此时,大鼠对静脉注射异丙肾上腺素的变时性和血压反应增强,表现为ED50值降低(与对照组相比分别降低2倍和12倍)。此外,心脏肌膜β受体数量和腺苷酸环化酶活性仍显著高于对照组;β受体数量增加35%,基础、氟化物、福斯高林和异丙肾上腺素刺激的腺苷酸环化酶活性分别增加96%、26%、13%和37%。停药48小时后,血清普萘洛尔浓度仅为0.5±0.1纳克/毫升,刚能检测到。虽然肌膜β受体数量仍升高(23%),但异丙肾上腺素刺激的腺苷酸环化酶活性已恢复到对照值。然而,氟化物和福斯高林刺激的酶活性分别比对照值降低了12%和23%,提示腺苷酸环化酶复合物的催化能力降低。与β受体数量和腺苷酸环化酶活性的降低同时,对静脉注射异丙肾上腺素的变时性反应也恢复到了对照值。相比之下,这些动物对静脉注射异丙肾上腺素的血压反应仍升高,与对照动物相比,ED50值降低了5倍。